Baidu
map

“提高腹膜透析治疗质量国际高峰论坛”顺利召开

2012-04-10 范振光 北大第一医院

    3月22日~24日,由北京大学肾脏病研究所、我院肾脏内科和国际腹膜透析学会主办、人民医院和第三医院肾脏内科共同协办的“提高腹膜透析治疗质量国际高峰论坛”在北京金台饭店顺利召开。卫生部医政司司长王羽、北京市卫生局领导邓小虹、医政处副处长路明、我院院长刘玉村、副院长丁洁出席了开幕式并做重要讲话。     1. &nbsp

腹膜透析 尿毒症 慢性肾脏病 腹膜炎
    3月22日~24日,由北京大学肾脏病研究所、我院肾脏内科和国际腹膜透析学会主办、人民医院和第三医院肾脏内科共同协办的“提高腹膜透析治疗质量国际高峰论坛”在北京金台饭店顺利召开。卫生部医政司司长王羽、北京市卫生局领导邓小虹、医政处副处长路明、我院院长刘玉村、副院长丁洁出席了开幕式并做重要讲话。
  腹膜透析 尿毒症 慢性肾脏病 腹膜炎   1.  全国腹透多中心队列研究结果首次发布(3月22日下午):       本次论坛旨在提高我国腹膜透析治疗质量,延长尿毒症患者生存时间,提高生存质量。会上,我院肾脏内科王海燕教授和赵明辉教授牵头的一项题为“社会经济水平对腹透患者预后的影响”的全国首家腹透多中心队列研究首次发布研究结果。人民医院、第三医院,复旦大学华山医院、上海交通大学仁济医院、浙江大学第一医院、哈尔滨医科大学附属第二医院、宁夏医科大学总医院肾脏内科主任参加了结题会。该研究共纳入8家腹透单位的2000余例患者,结果发现,中国低收入的腹透人群多在农村地区,自付透析费用较高,其死亡率和腹膜炎发生率均明显高于较高收入的腹透人群;在我国低GDP地区低收入人群的预后不良更为显著。研究提出了政策建议:为大幅度提高尿毒症患者救治率,我国应大规模针对高危人群开展规范化腹透治疗,强化对病人的教育及管理以改善预后。   2. 腹透高峰国际论坛(3月23日至24日)       过去5年,我国各级医疗机构开展和普及腹透技术的势态良好,各地腹透中心的患者数量普遍显著递增。因此,未来一段时间腹透发展的主攻方向是提高腹透治疗质量、提高病人的生存率和生活质量。   腹膜透析 尿毒症 慢性肾脏病 腹膜炎
      针对我国腹透发展前景、心血管并发症、腹膜炎和营养不良等热点话题,本次论坛邀请到了来自英国、加拿大、美国、瑞典、香港等地数位国际腹透专家,包括国际腹透学会的现任主席Simon Davies教授、候任主席Joanne Bargman教授、Rajnish Mehrotra教授、Bengt Lindholm教授Philip Li教授Angela Wang教授,以及我国肾脏病和血液净化领域的领军人物王海燕教授、王梅教授、余学清教授、赵明辉教授、姜宗培教授、左力教授、阳晓教授、陈丽萌教授等举行系列演讲。与会专家的精彩演讲得到了参会学员的热烈响应,现场互动积极,提问时间一再延时。来自全国各地的约200名肾脏科医生和护士参加了会议。这次论坛同时也是国际腹膜透析学会在中国的继续教育活动及北京大学医学部百年庆典的系列活动之一。论坛的成功举办显示了腹透领域的勃勃生机以及肾脏内科医生对于腹透的高度热情。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1988789, encodeId=2fde1988e894c, content=<a href='/topic/show?id=a8d264e07d9' target=_blank style='color:#2F92EE;'>#治疗质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64707, encryptionId=a8d264e07d9, topicName=治疗质量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Sun Jul 01 20:36:00 CST 2012, time=2012-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662844, encodeId=2e711662844ed, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Mon May 07 14:36:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361870, encodeId=c8ee13618e0d9, content=<a href='/topic/show?id=af418566519' target=_blank style='color:#2F92EE;'>#腹膜透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85665, encryptionId=af418566519, topicName=腹膜透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623723, encodeId=39511623e238e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1988789, encodeId=2fde1988e894c, content=<a href='/topic/show?id=a8d264e07d9' target=_blank style='color:#2F92EE;'>#治疗质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64707, encryptionId=a8d264e07d9, topicName=治疗质量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Sun Jul 01 20:36:00 CST 2012, time=2012-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662844, encodeId=2e711662844ed, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Mon May 07 14:36:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361870, encodeId=c8ee13618e0d9, content=<a href='/topic/show?id=af418566519' target=_blank style='color:#2F92EE;'>#腹膜透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85665, encryptionId=af418566519, topicName=腹膜透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623723, encodeId=39511623e238e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1988789, encodeId=2fde1988e894c, content=<a href='/topic/show?id=a8d264e07d9' target=_blank style='color:#2F92EE;'>#治疗质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64707, encryptionId=a8d264e07d9, topicName=治疗质量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Sun Jul 01 20:36:00 CST 2012, time=2012-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662844, encodeId=2e711662844ed, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Mon May 07 14:36:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361870, encodeId=c8ee13618e0d9, content=<a href='/topic/show?id=af418566519' target=_blank style='color:#2F92EE;'>#腹膜透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85665, encryptionId=af418566519, topicName=腹膜透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623723, encodeId=39511623e238e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1988789, encodeId=2fde1988e894c, content=<a href='/topic/show?id=a8d264e07d9' target=_blank style='color:#2F92EE;'>#治疗质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64707, encryptionId=a8d264e07d9, topicName=治疗质量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Sun Jul 01 20:36:00 CST 2012, time=2012-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662844, encodeId=2e711662844ed, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Mon May 07 14:36:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361870, encodeId=c8ee13618e0d9, content=<a href='/topic/show?id=af418566519' target=_blank style='color:#2F92EE;'>#腹膜透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85665, encryptionId=af418566519, topicName=腹膜透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623723, encodeId=39511623e238e, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-04-12 xuyong530

相关资讯

卷曲形与直形腹膜透析管

文献标题:Coiled versus straight peritoneal dialysis catheters: a randomized controlled trial and meta-analysis. 文献出处:Am J Kidney Dis. 2011 Dec;58(6):946-55. 期刊影响因子:5.242     腹膜透析管的设计存在许多不同方

使用氨基糖苷类治疗腹透相关性腹膜炎不会影响残余肾功能

    为研究使用氨基糖苷类对RRF的下降斜率的影响,研究纳入2715从2003年10月和2007年12月间接受腹透治疗的澳大利亚患者,至少用两种测量方法来计算肾脏肌酐清除率。根据RRF下降斜率的四分位(快速、中间、缓慢)将患者分类。主要观察终点是:一段时间过后,使用氨基糖甙类治疗PD相关性腹膜炎与没有使用者之间他们的RRF下降斜率的比较。     &n

Baidu
map
Baidu
map
Baidu
map